{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:39:01Z","timestamp":1769603941137,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,6,9]],"date-time":"2015-06-09T00:00:00Z","timestamp":1433808000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00726-015-2015-0","type":"journal-article","created":{"date-parts":[[2015,6,10]],"date-time":"2015-06-10T16:21:35Z","timestamp":1433953295000},"page":"1837-1845","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica"],"prefix":"10.1007","volume":"47","author":[{"given":"Aiden","family":"Haghikia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arslan Arinc","family":"Kayacelebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bibiana","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Hanff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Haghikia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Tsikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,9]]},"reference":[{"key":"2015_CR1","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1016\/j.ijcard.2013.07.099","volume":"168","author":"D Atzler","year":"2013","unstructured":"Atzler D, Rosenberg M, Andersso M, Choe CU, Lutz M, Zugck C et al (2013) Homoarginine\u2014an independent marker of mortality in heart failure. Int J Cardiol 168:4907\u20134909","journal-title":"Int J Cardiol"},{"key":"2015_CR2","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1161\/ATVBAHA.114.304398","volume":"34","author":"D Atzler","year":"2014","unstructured":"Atzler D, Gore MO, Ayers CR, Choe CU, B\u00f6ger RH, de Lemos JA, McGuire DK, Schwedhelm E (2014) Homoarginine and cardiovascular outcome in the population-based Dallas Heart Study. Arterioscler Thromb Vasc Biol 34:2501\u20132507","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2015_CR3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.phrs.2009.07.001","volume":"60","author":"RH B\u00f6ger","year":"2009","unstructured":"B\u00f6ger RH, Maas R, Schulze F, Schwedhelm E (2009) Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality\u2014an update on patient populations with a wide range of cardiovascular risk. Pharmacol Res 60:481\u2013487","journal-title":"Pharmacol Res"},{"key":"2015_CR4","doi-asserted-by":"crossref","first-page":"46789","DOI":"10.1074\/jbc.M306787200","volume":"278","author":"LE Bretscher","year":"2003","unstructured":"Bretscher LE, Li H, Poulos TL, Griffith OW (2003) Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N5-(iminoalkyl)- and N5-(iminoalkenyl)-ornithines. J Biol Chem 278:46789\u201346797","journal-title":"J Biol Chem"},{"key":"2015_CR5","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/CIRCULATIONAHA.112.000580","volume":"128","author":"CU Choe","year":"2013","unstructured":"Choe CU, Atzler D, Wild PS, Carter AM, B\u00f6ger RH, Ojeda F, Simova O, Stockebrand M, Lackner K, Nabuurs C, Marescau B, Streichert T, Muller C, Luneburg N, De Deyn PP, Benndorf RA, Baldus S, Gerloff C, Blankenberg S, Heerschap A, Grant PJ, Magnus T, Zeller T, Isbrandt D, Schwedhelm E (2013) Homoarginine levels are regulated by l-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studies. Circulation 128:1451\u20131461","journal-title":"Circulation"},{"key":"2015_CR6","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/eurjhf\/hfr056","volume":"13","author":"C Drechsler","year":"2011","unstructured":"Drechsler C, Meinitzer A, Pilz S, Krane V, Tomaschitz A, Ritz E, M\u00e4rz W, Wanner C (2011) Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients. Eur J Heart Fail 13:852\u2013859","journal-title":"Eur J Heart Fail"},{"key":"2015_CR7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000107286","volume":"14","author":"AS Farias","year":"2007","unstructured":"Farias AS, de la Hoz C, Castro FR, Oliveira EC, Ribeiro dos Reis JR, Silva JS, Langone F, Santos LM (2007) Nitric oxide and TNFalpha effects in experimental autoimmune encephalomyelitis demyelination. NeuroImmunoModulation 14:32\u201338","journal-title":"NeuroImmunoModulation"},{"key":"2015_CR8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1523\/JNEUROSCI.4706-06.2007","volume":"27","author":"A Haghikia","year":"2007","unstructured":"Haghikia A, Mergia E, Friebe A, Eysel UT, Koesling D, Mittmann T (2007) Long-term potentiation in the visual cortex requires both nitric oxide receptor guanylyl cyclases. J Neurosci 27:818\u2013823","journal-title":"J Neurosci"},{"key":"2015_CR9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.molmed.2013.03.004","volume":"19","author":"A Haghikia","year":"2013","unstructured":"Haghikia A, Hohlfeld R, Gold R, Fugger L (2013) Therapies for multiple sclerosis: translational achievements and outstanding needs. Trends Mol Med 19:309\u2013319","journal-title":"Trends Mol Med"},{"key":"2015_CR10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jchromb.2006.09.023","volume":"851","author":"JD Horowitz","year":"2007","unstructured":"Horowitz JD, Heresztyn T (2007) An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: methodological considerations. J Chromatogr B 851:42\u201350","journal-title":"J Chromatogr B"},{"key":"2015_CR11","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s00726-014-1774-3","volume":"46","author":"AA Kayacelebi","year":"2014","unstructured":"Kayacelebi AA, Beckmann B, Gutzki FM, Jordan J, Tsikas D (2014a) GC\u2013MS and GC\u2013MS\/MS measurement of the cardiovascular risk factor homoarginine in biological samples. Amino Acids 46:2205\u20132217","journal-title":"Amino Acids"},{"key":"2015_CR12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ijcard.2014.07.296","volume":"176","author":"AA Kayacelebi","year":"2014","unstructured":"Kayacelebi AA, Pham VV, Willers J, Hahn A, Stichtenoth DO, Jordan J, Tsikas D (2014b) Plasma homoarginine (hArg) and asymmetric dimethylarginine (ADMA) in patients with rheumatoid arthritis: is homoarginine a cardiovascular corrective in rheumatoid arthritis, an anti-ADMA? Int J Cardiol 176:1129\u20131131","journal-title":"Int J Cardiol"},{"key":"2015_CR13","author":"AA Kayacelebi","year":"2015","unstructured":"Kayacelebi AA, Kn\u00f6fel AK, Beckmann B, Hanff E, Warnecke G, Tsikas D (2015) Measurement of unlabeled and stable isotope-labeled homoarginine, arginine and their metabolites in biological samples by GC-MS and GC-MS\/MS. Amino Acids. doi: 10.1007\/s00726-015-1984-3","journal-title":"Amino Acids"},{"key":"2015_CR14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/jhh.2011.109","volume":"27","author":"AA Khalil","year":"2013","unstructured":"Khalil AA, Tsikas D, Akolekar R, Jordan J, Nicolaides KH (2013) Asymmetric dimethylarginine, arginine and homoarginine at 11\u201313\u00a0weeks\u2019 gestation and preeclampsia: a case-control study. J Hum Hypertens 27:38\u201343","journal-title":"J Hum Hypertens"},{"key":"2015_CR15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.niox.2007.05.005","volume":"17","author":"A Kielstein","year":"2007","unstructured":"Kielstein A, Tsikas D, Galloway GP, Mendelson JE (2007) Asymmetric dimethylarginine (ADMA)\u2014a modulator of nociception in opiate tolerance and addiction? Nitric Oxide 17:55\u201359","journal-title":"Nitric Oxide"},{"key":"2015_CR16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0008-6363(99)00162-5","volume":"43","author":"J Leiper","year":"1999","unstructured":"Leiper J, Vallance P (1999) Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 43:542\u2013548","journal-title":"Cardiovasc Res"},{"key":"2015_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00228-005-0013-y","volume":"26","author":"JM Leiper","year":"2006","unstructured":"Leiper JM, Vallance P (2006) The synthesis and metabolism of asymmetric dimethylarginine (ADMA). Eur J Clin Pharmacol 26:33\u201338","journal-title":"Eur J Clin Pharmacol"},{"key":"2015_CR34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jns.2012.03.015","volume":"318","author":"S Ljubisavljevic","year":"2012","unstructured":"Ljubisavljevic S, Stevanovic I, Pavlovic R, Sokolovic D, Pavlovic D, Cvetkovic T (2012) J Neurol Sci 318:106\u2013111","journal-title":"J Neurol Sci"},{"key":"2015_CR18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","volume":"14","author":"DH Mahad","year":"2015","unstructured":"Mahad DH, Trapp BD, Lassmann H (2015) Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol 14:183\u2013193","journal-title":"Lancet Neurol"},{"key":"2015_CR19","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIRCULATIONAHA.109.908988","volume":"122","author":"W M\u00e4rz","year":"2010","unstructured":"M\u00e4rz W, Meinitzer A, Drechsler C, Pilz S, Krane V, Kleber ME, Fischer J, Winkelmann BR, B\u00f6hm BO, Ritz E, Wanner C (2010) Homoarginine, cardiovascular risk, and mortality. Circulation 122:967\u2013975","journal-title":"Circulation"},{"key":"2015_CR20","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/ijms15011189","volume":"15","author":"M May","year":"2014","unstructured":"May M, Batkai S, Z\u00f6rner AA, Tsikas D, Jordan J, Engeli S (2014) Clinical evaluation of extracellular ADMA concentrations in human blood and adipose tissue. Int J Mol Sci 15:1189\u20131200","journal-title":"Int J Mol Sci"},{"key":"2015_CR21","author":"M May","year":"2015","unstructured":"May M, Kayacelebi AA, Batkai S, Jordan J, Tsikas D, Engeli S (2015) Plasma and tissue homoarginine concentrations in healthy and obese humans. Amino Acids. doi: 10.1007\/s00726-015-1922-4","journal-title":"Amino Acids"},{"key":"2015_CR22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0306-4522(94)90435-9","volume":"3","author":"B Mitrovic","year":"1994","unstructured":"Mitrovic B, Ignarro LJ, Montestruque S, Smoll A, Merrill JE (1994) Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 3:575\u2013585","journal-title":"Neuroscience"},{"key":"2015_CR23","doi-asserted-by":"crossref","first-page":"10453","DOI":"10.1021\/bi980742t","volume":"37","author":"C Moali","year":"1998","unstructured":"Moali C, Boucher JL, Sari MA, Stuehr DJ, Mansuy D (1998) Substrate specificity of NO synthases: detailed comparison of l-arginine, homo-l-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-l-arginine. Biochemistry 37:10453\u201310460","journal-title":"Biochemistry"},{"key":"2015_CR24","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1021\/bi992992v","volume":"39","author":"C Moali","year":"2000","unstructured":"Moali C, Brollo M, Custot J, Sari MA, Boucher JL, Stuehr DJ, Mansuy D (2000) Recognition of alpha-amino acids bearing various C=NOH functions by nitric oxide synthase and arginase involves very different structural determinants. Biochemistry 39:8208\u20138218","journal-title":"Biochemistry"},{"key":"2015_CR25","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","volume":"329","author":"S Moncada","year":"1993","unstructured":"Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. New Engl J Med 329:2002\u20132012","journal-title":"New Engl J Med"},{"key":"2015_CR26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","volume":"10","author":"MC Papadopoulos","year":"2014","unstructured":"Papadopoulos MC, Bennett JL, Verkman AL (2014) Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nat Rev Neurol 10:493\u2013506","journal-title":"Nat Rev Neurol"},{"key":"2015_CR27","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/STROKEAHA.110.603035","volume":"42","author":"S Pilz","year":"2011","unstructured":"Pilz S, Tomaschitz A, Meinitzer A, Drechsler C, Ritz E, Krane V, Wanner C, Bohm BO, M\u00e4rz W (2011) Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography. Stroke 42:1132\u20131134","journal-title":"Stroke"},{"key":"2015_CR28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/eci.12208","volume":"44","author":"S Pilz","year":"2014","unstructured":"Pilz S, Teerlink T, Scheffer PG, Meinitzer A, Rutters F, Tomaschitz A, Drechsler C, Kienreich K, Nijpels G, Stehouwer CD, M\u00e4rz W, Dekker JM (2014) Homoarginine and mortality in an older population: the Hoorn study. Eur J Clin Invest 44:200\u2013208","journal-title":"Eur J Clin Invest"},{"key":"2015_CR29","author":"S Pilz","year":"2015","unstructured":"Pilz S, Meinitzer A, Gaksch M, Gr\u00fcbler M, Verheyen N, Drechsler C, Hartaigh B\u00d3, Lang F, Alesutan I, Voelkl J, M\u00e4rz W, Tomaschitz A (2015a) Homoarginine in the renal and cardiovascular systems. Amino Acids. doi: 10.1007\/s00726-015-1993-2","journal-title":"Amino Acids"},{"key":"2015_CR30","author":"S Pilz","year":"2015","unstructured":"Pilz S, Putz-Bankuti C, Meinitzer A, M\u00e4rz W, Kienreich K, Stojakovic T, Pieber TR, Stauber RE (2015b) Association of homoarginine and methylarginines with liver dysfunction and mortality in chronic liver disease. Amino Acids. doi: 10.1007\/s00726-015-2000-7","journal-title":"Amino Acids"},{"key":"2015_CR31","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1212\/01.WNL.0000142043.32578.5D","volume":"63","author":"K Redjak","year":"2004","unstructured":"Redjak K, Eikelenboom MJ, Petzold A, Thompson EJ, Stelmasiak Z, Lazeron RHC, Barkhof F, Polman CH, Uitdehaag BMJ, Giovannoni G (2004) CSF nitrite oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology 63:1439\u20131445","journal-title":"Neurology"},{"key":"2015_CR32","doi-asserted-by":"crossref","unstructured":"Sandoo A, Dimitroulas T, Hodson J, Smith JP, Douglas KM, Kitas GD (2014) Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6\u00a0year follow-up study. Rheumatology (Oxford). doi: 10.1093\/rheumatology\/keu349","DOI":"10.1093\/rheumatology\/keu349"},{"key":"2015_CR33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1474-4422(02)00102-3","volume":"1","author":"KJ Smith","year":"2002","unstructured":"Smith KJ, Lassmann H (2002) The role of nitric oxide in multiple sclerosis. Lancet Neurol 1:232\u2013241","journal-title":"Lancet Neurol"},{"key":"2015_CR35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jns.2012.09.014","volume":"323","author":"I Stojanovic","year":"2012","unstructured":"Stojanovic I, Vojinovic S, Ljubisavljevic S, Pavlovic R, Basic J, Pavlovic D, Ilic A, Cvetkovic T, Stukalov M (2012) INF-\u03b21b therapy modulates l-arginine and nitric oxide metabolism in patients with relapse remittent multiple sclerosis. J Neurol Sci 323:187\u2013192","journal-title":"J Neurol Sci"},{"key":"2015_CR36","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1021\/ac9913255","volume":"72","author":"D Tsikas","year":"2000","unstructured":"Tsikas D (2000) Simultaneous derivatization and quantification of the nitric oxide metabolites nitrite and nitrate in biological fluids by gas chromatography\/mass spectrometry. Anal Chem 72:4064\u20134072","journal-title":"Anal Chem"},{"key":"2015_CR37","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.jchromb.2009.01.005","volume":"877","author":"D Tsikas","year":"2009","unstructured":"Tsikas D (2009) De novo synthesis of trideuteromethyl esters of amino acids for use in GC\u2013MS and GC\u2013tandem MS exemplified for ADMA in human plasma and urine: standardization, validation, comparison and proof of evidence for their aptitude as internal standards. J Chromatogr B 877:2308\u20132320","journal-title":"J Chromatogr B"},{"key":"2015_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2015.01.001","volume":"45C","author":"D Tsikas","year":"2015","unstructured":"Tsikas D (2015) Circulating and excretory nitrite and nitrate: their value as measures of nitric oxide synthesis, bioavailability and activity is inherently limited. Nitric Oxide 45C:1\u20133","journal-title":"Nitric Oxide"},{"key":"2015_CR39","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1253\/circj.CJ-14-0484","volume":"78","author":"D Tsikas","year":"2014","unstructured":"Tsikas D, Kayacelebi AA (2014) Do homoarginine and asymmetric dimethylarginine act antagonistically in the cardiovascular system? Circ J 78:2094\u20132095","journal-title":"Circ J"},{"key":"2015_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(00)01686-0","volume":"478","author":"D Tsikas","year":"2000","unstructured":"Tsikas D, B\u00f6ger RH, Sandmann J, Bode-B\u00f6ger SM, Fr\u00f6lich JC (2000a) Endogenous nitric oxide synthase inhibitors are responsible for the l-arginine paradox. FEBS Lett 478:1\u20133","journal-title":"FEBS Lett"},{"key":"2015_CR41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0378-4347(00)00142-0","volume":"742","author":"D Tsikas","year":"2000","unstructured":"Tsikas D, Sandmann J, Savva A, Luessen P, B\u00f6ger RH, Gutzki FM, Fr\u00f6lich JC (2000b) Assessment of nitric oxide synthase activity in vitro and in vivo by gas chromatography\u2013mass spectrometry. J Chromatogr B 742:143\u2013153","journal-title":"J Chromatogr B"},{"key":"2015_CR42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jchromb.2003.09.001","volume":"798","author":"D Tsikas","year":"2003","unstructured":"Tsikas D, Schubert B, Gutzki FM, Sandmann J, Fr\u00f6lich JC (2003) Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography\u2013tandem mass spectrometry as methyl ester tri(N-pentafluoropropionyl) derivative. J Chromatogr B 798:87\u201399","journal-title":"J Chromatogr B"},{"key":"2015_CR43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ab.2011.02.002","volume":"413","author":"D Tsikas","year":"2011","unstructured":"Tsikas D, Beckmann B, Gutzki FM, Jordan J (2011) Simultaneous gas chromatography-tandem mass spectrometry quantification of symmetric and asymmetric dimethylarginine in human urine. Anal Biochem 413:60\u201362","journal-title":"Anal Biochem"},{"key":"2015_CR44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00726-008-0210-y","volume":"37","author":"G Wu","year":"2009","unstructured":"Wu G, Bazer FW, Davis TA, Kim SW, Li P, Marc Rhoads J, Carey Satterfield M, Smith SB, Spencer TE, Yin Y (2009) Arginine metabolism and nutrition in growth, health and disease. Amino Acids 37:153\u2013168","journal-title":"Amino Acids"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-015-2015-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-015-2015-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-015-2015-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:42:07Z","timestamp":1559108527000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-015-2015-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["2015"],"URL":"https:\/\/doi.org\/10.1007\/s00726-015-2015-0","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,9]]}}}